In addition, Western blot analysis showed reduction in NDST1 protein level in normal human fibroblast and MPS IIIA patient cells by 80% and in MPS I patient cells by 95% after 1 day with 2x IC50 of ITF 2357 treatment (Fig 6C). This evidence concerns the gene NDST1 and mucopolysaccharidosis type 3A.